Brief: Jiangsu Recbio Technology Says Acceptance By CSRC Of H Share Full Circulation Application Of Co
25/08/2022 15:38
Aug 25 (Reuters) - Jiangsu Recbio Technology Co Ltd
2179.HK :
* ACCEPTANCE BY CSRC OF H SHARE FULL CIRCULATION APPLICATION
OF CO
Source text for Eikon: ID:nHKSl6NzG
Further company coverage: 2179.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Jiangsu Recbio Technology
See all newsBrief: Jiangsu Recbio Technology To Re-Plan Timetable For HPV Vaccine Marketing Application
Brief: Jiangsu Recbio Technology Says New Drug Application For REC610 Shingles Vaccine Accepted By NMPA
Brief: Jiangsu Recbio Technology Says Liu Yong Resigned As Chair
Brief: Jiangsu Recbio Technology Says Li Bu Resigned As Executive Director
Brief: Jiangsu Recbio Technology Says Acceptance By CSRC Of Application Materials For Issuance Of Shares